JP2025512049A5 - - Google Patents
Info
- Publication number
- JP2025512049A5 JP2025512049A5 JP2024560403A JP2024560403A JP2025512049A5 JP 2025512049 A5 JP2025512049 A5 JP 2025512049A5 JP 2024560403 A JP2024560403 A JP 2024560403A JP 2024560403 A JP2024560403 A JP 2024560403A JP 2025512049 A5 JP2025512049 A5 JP 2025512049A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- optionally
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP220100953A AR125352A1 (es) | 2020-02-24 | 2022-04-13 | Lípidos catiónicos a base de tampones de good |
| ARP20220100953 | 2022-04-13 | ||
| TW111114318 | 2022-04-14 | ||
| TW111114318A TW202309002A (zh) | 2021-04-15 | 2022-04-14 | 基於「古德」緩衝液的陽離子脂質 |
| PCT/US2022/025067 WO2022221688A1 (en) | 2021-04-15 | 2022-04-15 | "good"buffer-based cationic lipids |
| USPCT/US2022/025067 | 2022-04-15 | ||
| EP23305491 | 2023-04-04 | ||
| EP23305491.5 | 2023-04-04 | ||
| PCT/EP2023/059726 WO2023198857A1 (en) | 2022-04-13 | 2023-04-13 | "good" buffer-based cationic lipids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512049A JP2025512049A (ja) | 2025-04-16 |
| JP2025512049A5 true JP2025512049A5 (enExample) | 2026-04-21 |
Family
ID=86226317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560403A Pending JP2025512049A (ja) | 2022-04-13 | 2023-04-13 | 「ｇｏｏｄ」緩衝液ベースのカチオン性脂質 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250263385A1 (enExample) |
| EP (1) | EP4508039A1 (enExample) |
| JP (1) | JP2025512049A (enExample) |
| CN (2) | CN121285547A (enExample) |
| WO (1) | WO2023198857A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026008743A1 (en) | 2024-07-02 | 2026-01-08 | Sanofi Pasteur Inc. | Water-soluble polyanionic polymer as adjuvant for carrier-formulated nucleic acid |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| TR201811076T4 (tr) | 2009-06-10 | 2018-08-27 | Arbutus Biopharma Corp | Geliştirilmiş lipit formulasyonu. |
| MA46762A (fr) | 2016-11-10 | 2019-09-18 | Translate Bio Inc | Procédé amélioré de préparation de nanoparticules lipidiques chargées d'arnm |
| ES2972014T3 (es) * | 2019-04-22 | 2024-06-10 | Translate Bio Inc | Lípidos catiónicos de tioéster |
| US12453759B2 (en) * | 2019-05-03 | 2025-10-28 | Translate Bio, Inc. | Di-thioester cationic lipids |
| WO2020257611A1 (en) * | 2019-06-21 | 2020-12-24 | Translate Bio, Inc. | Cationic lipids comprising an hydroxy moiety |
| EP4216933B1 (en) | 2020-09-23 | 2024-09-18 | Translate Bio, Inc. | Piperazine-based cationic lipids |
| US11771652B2 (en) | 2020-11-06 | 2023-10-03 | Sanofi | Lipid nanoparticles for delivering mRNA vaccines |
| TW202309002A (zh) | 2021-04-15 | 2023-03-01 | 美商轉譯生技公司 | 基於「古德」緩衝液的陽離子脂質 |
-
2023
- 2023-04-13 JP JP2024560403A patent/JP2025512049A/ja active Pending
- 2023-04-13 EP EP23719728.0A patent/EP4508039A1/en active Pending
- 2023-04-13 CN CN202380046217.3A patent/CN121285547A/zh active Pending
- 2023-04-13 CN CN202510407099.5A patent/CN121318878A/zh active Pending
- 2023-04-13 US US18/856,198 patent/US20250263385A1/en active Pending
- 2023-04-13 WO PCT/EP2023/059726 patent/WO2023198857A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023542944A5 (enExample) | ||
| JP2023513720A5 (enExample) | ||
| KR100554344B1 (ko) | 소포성 복합체와 이의 제조 및 사용방법 | |
| CN112789031B (zh) | 用于核酸递送的包含脂化的阳离子肽化合物的脂质纳米颗粒制剂 | |
| JP2017536092A5 (enExample) | ||
| US20090074851A1 (en) | Cpg-packaged liposomes | |
| JP2024546431A5 (enExample) | ||
| JP5277439B2 (ja) | 核酸内包高分子ミセル複合体 | |
| JP2006519781A5 (enExample) | ||
| JP2024503441A5 (enExample) | ||
| JP2002512026A5 (enExample) | ||
| JP2021517471A5 (enExample) | ||
| JP2025500824A5 (enExample) | ||
| JP2025501731A5 (enExample) | ||
| JP2002540076A (ja) | ワクチン組成物 | |
| JP2021515037A5 (enExample) | ||
| JP2012525410A5 (enExample) | ||
| JP2025509507A5 (enExample) | ||
| CA2399790A1 (en) | Cd40 ligand adjuvant for respiratory syncytial virus | |
| CN116898848A (zh) | 治疗肺部疾病的高穿透力前药组合物和医药组合物 | |
| EP2300494A1 (en) | Anti-amyloid immunogenic compositions, methods and uses | |
| JP2023545924A5 (enExample) | ||
| JP2003509470A (ja) | 抗原に対するｃｄ８＋ｔ細胞免疫応答を増強するための複製欠損性アデノウイルスベクターの使用 | |
| JP2025500880A5 (enExample) | ||
| CN117482066B (zh) | 脂质组合物和用于脂质组合物的化合物 |